Published in J Clin Oncol on January 01, 1992
Anthracyclines: cardiotoxicity and its prevention. Arch Dis Child (1994) 0.85
Taxol dose intensification and its clinical implications. J Natl Med Assoc (1993) 0.81
Adapting antibodies for clinical use. BMJ (1992) 0.80
Osteosarcoma: more news on the good news despite crude tools. J Clin Oncol (1992) 0.75
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol (1992) 3.86
Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res (1984) 3.67
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med (1986) 3.27
Chemotactic peptide modulation of actin assembly and locomotion in neutrophils. J Cell Biol (1984) 2.38
A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia. Cancer (1972) 2.25
Fatalities during remission of childhood leukemia. Blood (1972) 2.08
Stage I-II pediatric Hodgkin's disease: long-term follow-up demonstrates equivalent survival rates following different management schemes. J Clin Oncol (1990) 2.02
Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital. N Engl J Med (1993) 1.99
Is primitive neuroectodermal tumor of the kidney a distinct entity? Cancer (1997) 1.99
Prevention of central nervous system leukemia by irradiation. Cancer (1973) 1.96
Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. J Clin Oncol (1989) 1.85
HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood (1993) 1.76
Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. N Engl J Med (1988) 1.65
A reappraisal of the results of stopping therapy in childhood leukemia. N Engl J Med (1979) 1.64
Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity. Pediatr Blood Cancer (2004) 1.61
Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. Clin Orthop Relat Res (1991) 1.56
Benefit of intensified therapy for patients with local or regional embryonal rhabdomyosarcoma: results from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol (2000) 1.56
Cessation of therapy during complete remission of childhood acute lymphocytic leukemia. N Engl J Med (1974) 1.55
Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors. J Pediatr Hematol Oncol (2000) 1.49
Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol (2001) 1.48
Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: report of three cases and review of the literature. J Clin Oncol (1992) 1.47
Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X. J Clin Oncol (1991) 1.42
Direct translation of a protracted irinotecan schedule from a xenograft model to a phase I trial in children. J Clin Oncol (1999) 1.41
Acquired von Willebrand's syndrome in systemic lupus erythematosus. Blood (1968) 1.40
Metastatic small cell tumor of bone with 'true' rosettes and glial fibrillary acidic protein positivity. Am J Clin Pathol (1991) 1.39
Von Willebrand's disease: a comparative study of diagnostic tests. J Pediatr (1968) 1.39
Presurgical window of carboplatin and surgery and multidrug chemotherapy for the treatment of newly diagnosed metastatic or unresectable osteosarcoma: Pediatric Oncology Group Trial. J Pediatr Hematol Oncol (2001) 1.37
Bone sarcomas of the head and neck in children: the St Jude Children's Research Hospital experience. Cancer (2000) 1.37
The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood (1990) 1.36
The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias. Blood (1991) 1.31
Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group study. Blood (1993) 1.30
A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Int J Radiat Oncol Biol Phys (1998) 1.27
Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain. J Exp Med (1989) 1.26
Intensity of immunosuppressive therapy and the incidence of Pneumocystis carinii pneumonitis. Cancer (1975) 1.22
Common mechanism of chromosome inversion in B- and T-cell tumors: relevance to lymphoid development. Science (1986) 1.21
Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood (1994) 1.21
Comparison of two methods of preventing central nervous system leukemia. Blood (1973) 1.19
Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Lancet (1987) 1.18
A semiautomatic one-stage factor 8 assay with a commercially prepared standard. J Lab Clin Med (1967) 1.18
Meningococcemia associated with intravascular coagulation. Pediatrics (1967) 1.17
Blood coagulation in thyroid dysfunction. N Engl J Med (1965) 1.16
Sarcomas (other than Ewing's) of flat bones in children and adolescents. A clinicopathologic study. Cancer (1990) 1.15
Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study. J Clin Oncol (1998) 1.13
Detection of the (11;22)(q24;q12) translocation of Ewing's sarcoma and peripheral neuroectodermal tumor by reverse transcription polymerase chain reaction. Am J Pathol (1993) 1.13
What constitutes optimal therapy for patients with rhabdomyosarcoma of the female genital tract? Cancer (2001) 1.11
Therapy of localized and regional lymphosarcoma of childhood. Cancer (1971) 1.11
Cytogenetic and immunophenotypic analysis of cell lines established from patients with T cell leukemia/lymphoma. Blood (1986) 1.11
A unique human B lymphocyte antigen defined by a monoclonal antibody. Hybridoma (1984) 1.11
Ewing's sarcoma--routine diagnostic utilization of MIC2 analysis: a Pediatric Oncology Group/Children's Cancer Group Intergroup Study. Hum Pathol (1994) 1.10
Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia. Lancet (1984) 1.10
Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study. J Clin Oncol (1999) 1.09
Clinical and biologic characterization of T-cell neoplasias with rearrangements of chromosome 7 band q34. Blood (1988) 1.09
Dynamic magnetic resonance imaging of regional contrast access as an additional prognostic factor in pediatric osteosarcoma. Cancer (2001) 1.08
Childhood acute lymphocytic leukemia: study VIII. Cancer (1978) 1.07
The current status of the treatment of childhood acute lymphoblastic leukemia. Cancer Treat Rev (1976) 1.07
Response to combination therapy after relapse in childhood acute lymphocytic leukemia. Cancer (1972) 1.06
Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis. Cancer (1992) 1.06
Thyroid dysfunction after radiotherapy in children with Hodgkin's disease. Cancer (1984) 1.05
Combined modality therapy of acute lymphocytic leukemia. Cancer (1975) 1.04
ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience. J Clin Oncol (1994) 1.04
Changing pattern of pulmonary metastases with adjuvant chemotherapy in patients with osteosarcoma: results from the multiinstitutional osteosarcoma study. J Clin Oncol (1991) 1.03
Brain metastases in osteosarcoma. Report of a long-term survivor and review of the St. Jude Children's Research Hospital experience. Cancer (1993) 1.03
Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects. Clin Pharmacol Ther (1991) 1.03
Therapy for localized Ewing's sarcoma of bone. J Clin Oncol (1989) 1.03
Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease. J Clin Oncol (1987) 1.03
High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis. Blood (1996) 1.02
Second malignant neoplasms occuring in survivors of osteosarcoma. Cancer (1997) 1.02
Aggressive management of second primary tumors in survivors of hereditary retinoblastoma. Int J Radiat Oncol Biol Phys (1989) 1.02
New modalities for treating chronic pancreatitis. Endoscopy (1989) 1.01
The treatment of acute lymphoblastic leukaemia. Br J Haematol (1980) 1.01
Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior. Hum Pathol (1999) 1.01
Five years after central nervous system irradiation of children with leukemia. Int J Radiat Oncol Biol Phys (1976) 1.00
Quantitation and estimation of lymphocyte subsets in tissue sections. Comparison with flow cytometry. Am J Clin Pathol (1987) 0.99
Thrombopoiesis. Semin Hematol (1967) 0.98
Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood (1986) 0.98
Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Res (1997) 0.98
A unique antigen on mature B cells defined by a monoclonal antibody. J Immunol (1986) 0.97
Initial features and prognosis in 363 children with acute lymphocytic leukemia. Cancer (1975) 0.97
Fractionated cylophosphamide and back to back high dose methotrexate and cytosine arabinoside improves outcome in patients with stage III high grade small non-cleaved cell lymphomas (SNCCL): a randomized trial of the Pediatric Oncology Group. Med Pediatr Oncol (1997) 0.97
Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy. J Pediatr Hematol Oncol (1998) 0.97
Discordance between surface and cytoplasmic expression of the Leu-4 (T3) antigen in thymocytes and in blast cells from childhood T lymphoblastic malignancies. J Clin Invest (1985) 0.96
Outcome in 43 children presenting with metastatic Ewing sarcoma: the St. Jude Children's Research Hospital experience, 1962 to 1992. Med Pediatr Oncol (1996) 0.96
MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol (1994) 0.96
P-glycoprotein expression at diagnosis may not be a primary mechanism of therapeutic failure in childhood rhabdomyosarcoma. J Clin Oncol (1996) 0.96
Improved results of treatment of adult acute lymphoblastic leukemia. Blood (1987) 0.95
Long-term neurological implications of somnolence syndrome in children with acute lymphocytic leukemia. Ann Neurol (1980) 0.95
Controversies in the management of paratesticular rhabdomyosarcoma: is staging retroperitoneal lymph node dissection necessary for adolescents with resected paratesticular rhabdomyosarcoma? Semin Pediatr Surg (2001) 0.94
Dextromethorphan and caffeine as probes for simultaneous determination of debrisoquin-oxidation and N-acetylation phenotypes in children. Clin Pharmacol Ther (1989) 0.94
Seizures in childhood lymphoblastic leukaemia patients. Lancet (1984) 0.93
Megakaryocytopoiesis in experimental iron deficiency anemia. Blood (1974) 0.93
Late mortality in childhood cancer: two excellent studies bring good news tempered by room for improvement. J Clin Oncol (2001) 0.93
Absence of Ig V region gene somatic hypermutation in advanced Burkitt's lymphoma. J Immunol (1989) 0.93
Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. J Clin Oncol (1999) 0.92
Platelet production in experimental iron deficiency anemia. Blood (1973) 0.92
Understanding academic medical centers: Simone's Maxims. Clin Cancer Res (1999) 0.92
Ifosfamide, Fanconi's syndrome, and rickets. J Clin Oncol (1991) 0.92
A second nonrandom translocation, der(16)t(1;16)(q21;q13), in Ewing sarcoma and peripheral neuroectodermal tumor. Cytogenet Cell Genet (1990) 0.92
Ewing's sarcoma: local tumor control and patterns of failure following limited-volume radiation therapy. Int J Radiat Oncol Biol Phys (1991) 0.91